Showing 1981-1990 of 3180 results for "".
Therapeutic Focus: Rosacea
https://practicaldermatology.com/topics/general-topics/therapeutic-focus-rosacea/21060/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21123/Preparation: The Cornerstone for Effective, Efficient EHR Use
https://practicaldermatology.com/topics/practice-management/preparation-the-cornerstone-for-effective-efficient-ehr-use/21269/Psoriasis and the Metabolic Syndrome
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-the-metabolic-syndrome/21535/Growing data support the notion that TNF inhibitors may decrease various risk factors for the metabolic syndrome.EHR User Series: Part I
https://practicaldermatology.com/topics/practice-management/ehr-user-series-part-i/22966/A Q&A series with users of EHR technology about their own experience and their broader impressions of EHR in dermatology.Combination approaches using Topical Vitamin D for Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-approaches-using-topical-vitamin-d-for-psoriasis/22920/A combination of topical vitamin D with some form of phototherapy and/or systemic therapy is a safe and effective option for plaque psoriasis.Examining the Implications of Stage 2 of the EHR Incentive Program
https://practicaldermatology.com/topics/practice-management/examining-the-implications-of-stage-2-of-the-ehr-incentive-program/21564/Requirements for patient involvement via portals may spell headaches for physicians hoping to qualify for government incentives in 2014.Harnessing Mobile Technology in Concert with EHRs
https://practicaldermatology.com/topics/practice-management/harnessing-mobile-technology-in-concert-with-ehrs/21637/Significant developments are on the way, but already EHRs offer unique abilities via mobile and tablet technologies.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21961/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.